Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases
Authors
Keywords
Breast cancer, Brain metastases, HER2, T-DM1, Toxicity, Efficacy
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 157, Issue 2, Pages 307-318
Publisher
Springer Nature
Online
2016-05-11
DOI
10.1007/s10549-016-3828-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Response of symptomatic brain metastases from HER-2 overexpressing breast cancer with T-DM1
- (2016) C. L. Gorter de Vries et al. JOURNAL OF NEURO-ONCOLOGY
- Response assessment criteria for brain metastases: proposal from the RANO group
- (2015) Nancy U Lin et al. LANCET ONCOLOGY
- Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer
- (2015) Azeem Saleem et al. EJNMMI Research
- Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA
- (2014) I. E. Krop et al. ANNALS OF ONCOLOGY
- Trastuzumab emtansine and stereotactic radiosurgery: an unexpected increase in clinically significant brain edema
- (2014) J. A. Carlson et al. NEURO-ONCOLOGY
- Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective study
- (2014) Aki Morikawa et al. NEURO-ONCOLOGY
- Brain metastases in HER2-positive metastatic breast cancer patients who received chemotherapy with or without trastuzumab
- (2014) Muhammet Ali Kaplan et al. Breast Cancer
- Comparative performances of prognostic indexes for breast cancer patients presenting with brain metastases
- (2013) Antoine-Laurent Braccini et al. BMC CANCER
- Prognostic factors of brain metastases from breast cancer: Impact of targeted therapies
- (2013) Antoine Laurent Braccini et al. BREAST
- Breast cancer brain metastases responding to primary systemic therapy with T-DM1
- (2013) Rupert Bartsch et al. JOURNAL OF NEURO-ONCOLOGY
- Brain metastases free survival differs between breast cancer subtypes
- (2012) A Berghoff et al. BRITISH JOURNAL OF CANCER
- A phase II study of lapatinib for brain metastases in patients with HER2-overexpressing breast cancer following trastuzumab based systemic therapy and cranial radiotherapy: subset analysis of Japanese patients
- (2012) Hiroji Iwata et al. International Journal of Clinical Oncology
- Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study
- (2012) Thomas Bachelot et al. LANCET ONCOLOGY
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
- (2012) Sunil Verma et al. NEW ENGLAND JOURNAL OF MEDICINE
- Correlation Between Quantitative HER-2 Protein Expression and Risk for Brain Metastases in HER-2+ Advanced Breast Cancer Patients Receiving Trastuzumab-Containing Therapy
- (2012) R. Duchnowska et al. ONCOLOGIST
- Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases
- (2011) Nancy U. Lin et al. JOURNAL OF NEURO-ONCOLOGY
- Carmustine and methotrexate in combination after whole brain radiation therapy in breast cancer patients presenting with brain metastases: a retrospective study
- (2010) William Jacot et al. BMC CANCER
- Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer
- (2009) N. U. Lin et al. CLINICAL CANCER RESEARCH
- Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer
- (2009) Makiko Ono et al. International Journal of Clinical Oncology
- Phase II Trial of Lapatinib for Brain Metastases in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
- (2008) Nancy U. Lin et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started